Castel David

Principal Investigator in pediatric neuro-oncology @GustaveRoussy @GOBT_Team @Inserm

[Gustavo Cruzeiro @Gavcruzeiro]

Our recently published manuscript in Cancer Cell – Diffuse hemispheric glioma, H3G34R/V-mutant (H3G34-DHG) - https://t.co/sIJB0fn1B9

[Institut Curie @institut_curie]

🏆Toutes nos félicitations à Geneviève Almouzni, lauréate pour l'Europe du Prix international @FondationLOreal @UNESCO #ForWomenInScience 2024 👏

#FWIS2024

[Vennetilab @vennetilab]

The amazing @JonesLabICR sporting Michigan swag and contemplating moving to Ann Arbor at the @chadtough #DIPG workshop.

[ChadTough Defeat DIPG Foundation @chadtough]

It was an incredible second day of our research workshop. Thank you to everyone who joined us!

It is amazing to see everyone come together with the common goal of defeating DIPG!

[Castel David @CastelDavid_Fr]

@vennetilab

[Castel David @CastelDavid_Fr]

Great time and discussions at the ChadTough Defeat DIPG Research Workshop in Ann Arbor.
Big thanks to Sriram @VennettiLab, Carl @CarlKoschmann and @ChadTough for the kind invitation to talk there.

[Castel David @CastelDavid_Fr]

Very proud that the work by @MarcoBruschi10 in our @GOBT_Team on #DMG invasion made it to the cover of @NeuOnc this month together with an editorial by Stephen C Mack !

https://t.co/VKUYgy8lR3

[Castel David @CastelDavid_Fr]

@Lucie_Auffret Thanks to @letoiledemartin @ImagineforMargo and la marche de l'ecureuil for their continuous support!

[Castel David @CastelDavid_Fr]

Very pleased to share work from @Lucie_Auffret in our @TeamGOBT on the identification of a new subgroup of #DMG H3 K27 and MAPK co-altered published in Acta Neuropathologica.
https://t.co/nu1x538Feb

[Team GOBT @GOBT_Team]

Lors d'une superbe soirée festive dans l'église du Pentemont, l'association @EnfantsCancersa officialisé son soutien à notre projet de recherche sur le #CMMRD en remettant un chèque à @MarcoBruschi10. Ce financement servira à mettre en place des modèles d'étude innovants. Merci!

[Castel David @CastelDavid_Fr]

@Lucie_Auffret 4- BRAF/FGFR1 mutated H3 K27-altered tumours have a better prognosis and show a transcriptomic signature of senescence

[Castel David @CastelDavid_Fr]

@Lucie_Auffret 3- DNA methylation profiling distinguishes the subgroup of DMG H3 K27-altered with MAPK-activating mutations